Andrew R. Allen, Director at Sierra Oncology, Inc. (SRRA), bought 66,000 shares at $1.64 ($108K) on 2018-12-10, disclosed to the SEC on 2018-12-11.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| CLVS | SELL | 2015-01-20 | $3.2M | — | Filing → |
| CLVS | SELL | 2013-06-07 | $1.5M | — | Filing → |
| CLVS | BUY | 2011-11-21 | $50K | — | Filing → |